Parse Biosciences has launched a fully integrated immune repertoire and whole transcriptome analysis workflow within its Trailmaker data analysis platform.
The update enables a complete end-to-end immune profiling solution. It complements Parse’s Evercode immune product portfolio and connects experimental data with downstream analysis in a single environment.
Immunologists often analyze:
But these datasets usually live in separate tools.
This fragmentation creates problems:
Trailmaker’s new functionality unifies these layers into one purpose-built platform.
Researchers can now:
The result is a complete view of:
By connecting repertoire data with transcriptome-wide expression, Trailmaker:
Researchers move faster from raw data to biological insight.
“Our goal has always been to remove barriers for researchers,” said Charlie Roco, PhD, co-founder and CTO of Parse Biosciences.
“By making immune profiling intuitive and more fully integrated, we’re empowering immunologists to spend less time wrangling data and more time assigning biological significance.”
Parse Biosciences develops accessible, scalable single-cell sequencing solutions.
Its technologies support research across:
The company’s mission is to accelerate progress in human health through high-scale single-cell biology.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!